{"product_id":"next-generation-sequencing-ngs-market-by-product-service-consumables-platforms-services-technology-sbs-nanopore-application-diagnostic-drug-discovery-agriculture-end-user-pharma-biotech-academic-global-forecast-to-2027","title":"Next-generation Sequencing (NGS) Market by Product \u0026 Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027","description":"\u003cp\u003eNext-generation Sequencing (NGS) Market by Product \u0026amp; Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.\u003c\/p\u003e\n\n\u003cp\u003eConsumables segment accounted for the largest share of next-generation sequencing market\u003c\/p\u003e \n\n\u003cp\u003eOn the basis of product \u0026amp; service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products \u0026amp; services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R\u0026amp;D activities in genomics.\u003c\/p\u003e \n\n\u003cp\u003eSequencing by synthesis segment accounted for the largest share of next-generation sequencing market\u003c\/p\u003e \n\n\u003cp\u003eBased on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.\u003c\/p\u003e\n\n\u003cp\u003eThe prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).\u003c\/p\u003e\n\n\u003cp\u003e“North America: Accounted for the largest share in the next-generation sequencing market”\u003c\/p\u003e\n\n\u003cp\u003eNorth America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 80% and Demand Side - 20%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%\u003c\/p\u003e\n\n\u003cp\u003eList of Companies Profiled in the Report:\u003c\/p\u003e \n\n\u003cp\u003eIllumina (US)\u003c\/p\u003e \n\n\u003cp\u003eThermo Fisher Scientific (US)\u003c\/p\u003e\n\n\u003cp\u003ePerkinElmer (US)\u003c\/p\u003e\n\n\u003cp\u003eBGI Group (China)\u003c\/p\u003e\n\n\u003cp\u003eAgilent Technologies (US)\u003c\/p\u003e\n\n\u003cp\u003eEurofins Scientific (Luxembourg)\u003c\/p\u003e\n\n\u003cp\u003ePacific Biosciences (US)\u003c\/p\u003e\n\n\u003cp\u003eOxford Nanopore Technologies (UK)\u003c\/p\u003e\n\n\u003cp\u003eQIAGEN (Netherlands)\u003c\/p\u003e\n\n\u003cp\u003eF. Hoffmann-La Roche AG (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eBrooks Automation (US)\u003c\/p\u003e\n\n\u003cp\u003ePsomagen, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003e10x Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003eTecan Group (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eZymo Research (US)\u003c\/p\u003e\n\n\u003cp\u003eTakara Bio (Japan)\u003c\/p\u003e\n\n\u003cp\u003ePromega Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eCD Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003eNew England Biolabs (US)\u003c\/p\u003e\n\n\u003cp\u003eNovogene Corporation (China)\u003c\/p\u003e \n\n\u003cp\u003eHamilton Company (US)\u003c\/p\u003e\n\n\u003cp\u003eMedGenome (US)\u003c\/p\u003e\n\n\u003cp\u003eBecton, Dickinson and Company (US)\u003c\/p\u003e\n\n\u003cp\u003eGenotypic Technology (India)\u003c\/p\u003e\n\n\u003cp\u003eLGC Limited (US)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 456 Pages \/ MCW16226960","offer_id":47640176099634,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/next-generation-sequencing-ngs-market-by-product-service-consumables-platforms-services-technology-sbs-nanopore-application-diagnostic-drug-discovery-agriculture-end-user-pharma-biotech-academic-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}